Genetic overlap between apparently sporadic motor neuron diseases

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Progressive Muscular Atrophy (PMA) and Amyotrophic Lateral Sclerosis (ALS) are debilitating motor neuron diseases (MNDs).
• These conditions lead to progressive muscle weakness and spasticity, significantly impacting patient quality of life.
• Understanding the genetic underpinnings of sporadic forms of these diseases is crucial for diagnosis and potential therapeutic strategies.

Purpose of the Study:

• To investigate and compare the frequencies of mutations in known motor neuron disease-associated genes.
• To determine if there is a genetic overlap between apparently sporadic PMA and sporadic ALS.
• To identify specific genetic variants contributing to the pathogenesis of these MNDs.

Main Methods:

• A cohort of 261 patients with adult-onset sporadic PMA, sporadic ALS, and control subjects of Dutch descent were recruited.
• Sanger sequencing was employed to screen for mutations in five key genes: SOD1, ANG, FUS/TLS, TARDBP, and CHMP2B.
• Mutation frequencies were statistically analyzed and compared between patient groups and controls.

Main Results:

• Several mutations were identified in the PMA cohort, including SOD1 (p.D90A, p.I113T), ANG (p.K17I), FUS/TLS (p.R521H), TARDBP (p.N352S), and a novel CHMP2B mutation (p.R69Q).
• The overall mutation frequency in the screened genes was comparable between sporadic PMA (2.7%) and sporadic ALS (2.0%) patients.
• These findings suggest a shared genetic etiology for both conditions.

Conclusions:

• The similar mutation frequencies in genes associated with MNDs between sporadic PMA and ALS patients indicate a significant genetic overlap.
• These results challenge the strict clinical distinction between PMA and ALS, suggesting they may represent a spectrum of the same disease.
• Further research into these shared genetic factors could lead to improved diagnostic tools and targeted therapies for motor neuron diseases.